A new study by Prof. Ariel Chipman of The Alexander Silberman Institute of Life Science at the Hebrew University of Jerusalem ...

Seven non-randomized comparative studies were identified (Figure 1). The basic strategy yielded 192 records. Fifty-four full texts were screened by titles and abstracts. Nineteen case reports ...

Patients with diabetes taking semaglutide had an absence of NAION risk at the 1-month, 3-month, 6-month, and 1-year time points after the index date. HealthDay News — For patients with diabetes ...